Artelo Biosciences Inc
(ARTL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARTL | AZN | AMGN | GILD | BMY |
| Company | Artelo Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.4200 | 194.02 | 377.04 | 151.47 | 60.94 |
| High | 1.4500 | 195.90 | 377.36 | 151.87 | 61.45 |
| Low | 1.4100 | 190.60 | 366.88 | 149.13 | 59.95 |
| Latest | 1.4200 | 193.46 | 368.54 | 149.54 | 60.72 |
| Change | -0.0300 | +5.45 | -7.28 | -2.14 | -0.05 |
| % Change | -2.07% | +2.90% | -1.94% | -1.41% | -0.08% |
| Volume | 9,234 | 1,992,735 | 1,232,634 | 4,119,283 | 6,247,730 |
| 20-Day Average Volume | 49,472 | 4,663,339 | 3,057,449 | 8,031,968 | 13,337,125 |
| Previous Close | 1.4500 | 188.01 | 375.82 | 151.68 | 60.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6225 | 187.38 | 347.68 | 137.38 | 56.48 |
| 20-Day Raw Stochastic | 13.23% | 87.92% | 73.68% | 88.33% | 82.30% |
| 20-Day Relative Strength | 40.50 | 57.73 | 61.65 | 70.77 | 67.28 |
| Weighted Alpha | -82.42 | +37.45 | +33.09 | +51.65 | +23.80 |
| Today's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 64% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.19% since 02/03/26 | +5.07% since 02/03/26 | +8.66% since 02/03/26 | +4.19% since 02/03/26 | +8.14% since 02/03/26 |
| Low | 1.3500 on 02/05/26 | 186.32 on 02/04/26 | 342.38 on 02/04/26 | 143.50 on 02/04/26 | 56.43 on 02/04/26 |
| High | 1.5600 on 02/04/26 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | unch since 01/09/26 | +2.30% since 01/09/26 | +12.83% since 01/09/26 | +23.28% since 01/09/26 | +8.39% since 01/09/26 |
| Low | 1.3500 on 02/05/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 1.8791 on 01/27/26 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -32.70% since 11/10/25 | +10.69% since 11/10/25 | +13.68% since 11/10/25 | +26.36% since 11/10/25 | +28.11% since 11/10/25 |
| Low | 1.1500 on 12/31/25 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 2.1400 on 11/11/25 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -82.99% since 08/08/25 | +31.65% since 08/08/25 | +27.65% since 08/08/25 | +25.02% since 08/08/25 | +31.76% since 08/08/25 |
| Low | 1.1500 on 12/31/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 10.5500 on 08/18/25 | 195.80 on 02/10/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,927 | 291,586,208 | 202,371,936 | 188,186,336 | 123,712,712 |
| Shares Outstanding, K | 2,019 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -9,830,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -3,120,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 1.12 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -3.97 on 11/12/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/02/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.12 | 17.59 | 18.62 | 10.08 |